Regenxbio (RGNX) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $28.1 million.
- Regenxbio's Receivables - Net rose 1709.43% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 1709.43%. This contributed to the annual value of $20.9 million for FY2024, which is 1782.59% down from last year.
- Latest data reveals that Regenxbio reported Receivables - Net of $28.1 million as of Q3 2025, which was up 1709.43% from $21.8 million recorded in Q2 2025.
- Regenxbio's Receivables - Net's 5-year high stood at $48.7 million during Q3 2021, with a 5-year trough of $16.4 million in Q1 2024.
- Moreover, its 5-year median value for Receivables - Net was $28.1 million (2025), whereas its average is $29.4 million.
- In the last 5 years, Regenxbio's Receivables - Net tumbled by 6121.34% in 2021 and then skyrocketed by 1864.72% in 2025.
- Regenxbio's Receivables - Net (Quarter) stood at $34.7 million in 2021, then fell by 14.74% to $29.6 million in 2022, then fell by 13.84% to $25.5 million in 2023, then dropped by 17.83% to $20.9 million in 2024, then soared by 34.21% to $28.1 million in 2025.
- Its Receivables - Net stands at $28.1 million for Q3 2025, versus $21.8 million for Q2 2025 and $19.4 million for Q1 2025.